PREMIER BIOMEDICAL INC - FORM 10-K/A - EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - June 1, 2020

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - PREMIER BIOMEDICAL INCbiei_ex312.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - PREMIER BIOMEDICAL INCbiei_ex321.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - PREMIER BIOMEDICAL INCbiei_ex311.htm
10-K/A - AMENDMENT NO 1 - PREMIER BIOMEDICAL INCbiei_10ka.htm
 
EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the Annual Report of Premier Biomedical, Inc. (the “Company”) on Form 10-K/A for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, David Caplan, Treasurer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)           
The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Dated: May 28, 2020
/s/ David Caplan
 
By: David Caplan
 
Its: Treasurer
 
 
A signed original of this written statement required by Section 906 has been provided to Premier Biomedical, Inc. and will be retained by Premier Biomedical, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 
 

PREMIER BIOMEDICAL INC Reports